Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Diagnosis of MCI was made according to the MDS criteria level II.
2
Methods: CC and FISH analyses were conducted for 216 primary MDS patients.
3
Clinical studies have demonstrated that decitabine has activity in patients with MDS.
4
Responses and outcomes were standardised according to the International Working Group MDS criteria.
5
A few recent case-control studies suggest an association between MDS and several occupations.
1
We report two THC2 patients misdiagnosed with myelodysplasia and treated with chemotherapy.
2
Cytopenia at day 30 was not significantly associated with later diagnosis of myelodysplasia.
3
Bone marrow biopsy done 3 months prior showed no significant myelodysplasia or lymphoid aggregates.
4
Results in myelodysplasia and aplastic anemia have been less encouraging.
5
However, there are very limited data on the development of hemophagocytosis or myelodysplasia in these patients.
1
Ten patients with preleukemia and life-threatening pancytopenia were treated with marrow transplantation.
2
Specimens were obtained from patients with preleukemia and associated antigen weakening, and from individuals with normal antigen values.
3
This experience also emphasizes the importance of performing chromosome studies before transplantation for pancytopenic states in order to identify cases of preleukemia.
1
Acute myeloid leukemia and myelodysplasticsyndromes represented the most common disease indications.
2
Objective: Unbalanced chromosomal aberrations are common in myelodysplasticsyndromes and have prognostic implications.
3
All patients belonged to the more aggressive subtypes of myelodysplasticsyndromes.
4
The relationship between these cytopenias and myeloid neoplasms like myelodysplasticsyndromes is currently poorly defined.
5
Results: Many rare germline mutations have been identified that lead to acute leukemia and myelodysplasticsyndromes.
Использование термина myelodysplastic syndrome на английском
1
A myelodysplasticsyndrome was noted 83 months from the start of therapy.
2
With these techniques, we studied a 61-year-old woman with a myelodysplasticsyndrome.
3
Case reports: A 76-year-old male with a known myelodysplasticsyndrome presented with pneumonia.
4
Additionally, two patients with primary mediastinal germ cell cancer developed a myelodysplasticsyndrome.
5
Sixteen children with myelodysplasticsyndrome as defined by the French-American-British co-operative group are presented.
6
The first patient developed myelogenous leukaemia soon after the myelodysplasticsyndrome has been diagnosed.
7
In three healthy subjects, we detected somatic aberrations characteristic of patients with myelodysplasticsyndrome.
8
Method: Prospective cohort study of 106 adults with chronic myelogenous leukemia or primary myelodysplasticsyndrome.
9
No acute myelogenous leukemia or myelodysplasticsyndrome was observed.
10
Treatment is feasible and well tolerated although myelodysplasticsyndrome cases has been observed in some trials.
11
Patients with refractory SAA are at risk of later clonal evolution to myelodysplasticsyndrome and acute leukemia.
12
Neither 13-Cis-Retinoic Acid nor Danazol appear active enough in patients with favorable myelodysplasticsyndrome to justify their use.
13
Its activation by chromosomal rearrangement induces a myelodysplasticsyndrome with progression to acute myeloid leukemia of poor prognosis.
14
One patient in aplastic anemia who achieved good response by ALG administration had a possible diagnosis of myelodysplasticsyndrome.
15
Chronic myelomonocytic leukaemia is a rare disease and data on the treatment are often extrapolated from myelodysplasticsyndrome studies.
16
The CMS avoided making a decision on EPO use for individuals with myelodysplasticsyndrome, which often develops into leukemia.